New drugs for HIV and hepatitis C virus infections: A report from CROI 2011

Research output: Contribution to journalArticle

Abstract

Presentations on new therapies for hepatitis C virus (HCV) generated the most excitement at CROI 2011. Two new, orally available, direct-acting antivirals, boceprevir and telaprevir, promise to usher in a new era of combination therapy for chronic HCV infection. The antiretroviral drug development pipeline continues to expand, albeit at a slower pace than in recent years.

Original languageEnglish (US)
Pages (from-to)485-490
Number of pages6
JournalDrugs of the Future
Volume36
Issue number6
DOIs
StatePublished - 2011

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'New drugs for HIV and hepatitis C virus infections: A report from CROI 2011'. Together they form a unique fingerprint.

Cite this